Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.

An underlying complex genetic susceptibility exists in multiple sclerosis (MS), and an association with the HLA-DRB1*1501-DQB1*0602 haplotype has been repeatedly demonstrated in high-risk (northern European) populations. It is unknown whether the effect is explained by the HLA-DRB1 or the HLA-DQB1 gene within the susceptibility haplotype, which are in strong linkage disequilibrium (LD). African populations are characterized by greater haplotypic diversity and distinct patterns of LD compared with northern Europeans. To better localize the HLA gene responsible for MS susceptibility, case-control and family-based association studies were performed for DRB1 and DQB1 loci in a large and well-characterized African American data set. A selective association with HLA-DRB1*15 was revealed, indicating a primary role for the DRB1 locus in MS independent of DQB1*0602. This finding is unlikely to be solely explained by admixture, since a substantial proportion of the susceptibility chromosomes from African American patients with MS displayed haplotypes consistent with an African origin.

[1]  Jan Engberg,et al.  Visualization of Myelin Basic Protein (Mbp) T Cell Epitopes in Multiple Sclerosis Lesions Using a Monoclonal Antibody Specific for the Human Histocompatibility Leukocyte Antigen (Hla)-Dr2–Mbp 85–99 Complex , 2000, The Journal of experimental medicine.

[2]  M. Carrington,et al.  DQ microsatellite association studies in three ethnic groups. , 1997, Tissue antigens.

[3]  N. Risch,et al.  Evidence for genetic basis of multiple sclerosis , 1996, The Lancet.

[4]  G. Dean,et al.  Multiple sclerosis among the United Kingdom-born children of immigrants from the West Indies. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[5]  C Oseroff,et al.  Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones , 1994, The Journal of experimental medicine.

[6]  A. Begovich,et al.  Selection for T-cell receptor Vβ–Dβ–Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis , 1993, Nature.

[7]  E R Martin,et al.  Letter to the Editor Correcting for a Potential Bias in the Pedigree Disequilibrium Test , 2022 .

[8]  F. Muntoni,et al.  DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. , 1998, Human molecular genetics.

[9]  W. Klitz,et al.  The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos. , 2002, Tissue antigens.

[10]  F. Koning,et al.  HLA‐DRβ chain residue 86 controls DRαβ dimer stability , 1993 .

[11]  Don C. Wiley,et al.  Crystal Structure of HLA-DR2 (DRA*0101, DRB1*1501) Complexed with a Peptide from Human Myelin Basic Protein , 1998, The Journal of experimental medicine.

[12]  F. Cucca,et al.  Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. , 2001, Human molecular genetics.

[13]  L. Excoffier,et al.  Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. , 1995, Molecular biology and evolution.

[14]  A. Zachary,et al.  HLA antigens, alleles, and haplotypes among African-Americans. , 1997, Transplantation proceedings.

[15]  L. Kappos,et al.  Myelin basic protein‐specific T lymphocyte lines from MS patients and healthy individuals , 1990, Neurology.

[16]  R J Albertini,et al.  T cells responsive to myelin basic protein in patients with multiple sclerosis. , 1990, Science.

[17]  Conrad C. Huang,et al.  The Structure Superposition Database , 2003, Nucleic Acids Res..

[18]  Alastair Compston,et al.  McAlpine's Multiple Sclerosis , 2005 .

[19]  P. Stastny,et al.  HLA class II haplotypes in Amerindians and in black North and South Americans. , 1991, Tissue antigens.

[20]  M. Alter,et al.  Distribution of multiple sclerosis. , 1973, Lancet.

[21]  J. Stephens,et al.  Significant admixture linkage disequilibrium across 30 cM around the FY locus in African Americans. , 2000, American journal of human genetics.

[22]  J. Hillert,et al.  Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. , 2000 .

[23]  G. Beebe,et al.  Epidemiology of multiple sclerosis in U.S. veterans , 1979, Neurology.

[24]  G. Modi,et al.  Demyelinating disorder of the central nervous system occurring in black South Africans , 2001, Journal of neurology, neurosurgery, and psychiatry.

[25]  M. King,et al.  African-American HLA class II allele and haplotype diversity. , 1996, Tissue antigens.

[26]  D. Allison,et al.  Estimating African American admixture proportions by use of population-specific alleles. , 1998, American journal of human genetics.

[27]  N Risch,et al.  Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. , 2001, American journal of human genetics.

[28]  Terence Dwyer,et al.  Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis. , 2002, American journal of human genetics.

[29]  C. Polman,et al.  Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region , 2002, Neurology.

[30]  E. Martin,et al.  A test for linkage and association in general pedigrees: the pedigree disequilibrium test. , 2000, American journal of human genetics.

[31]  R. Zinkernagel.  Maternal antibodies, childhood infections, and autoimmune diseases. , 2001, The New England journal of medicine.

[32]  S. Serjeantson,et al.  NOVEL HLA‐DR2‐RELATED HAPLOTYPES IN HONG KONG CHINESE IMPLICATE THE DQB1*0602 ALLELE IN SUSCEPTIBILITY TO MULTIPLE SCLEROSIS , 1992, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[33]  N. Risch,et al.  A genetic basis for familial aggregation in multiple sclerosis , 1995, Nature.

[34]  G. Schroth,et al.  Thrombolysis in patients with acute stroke caused by cervical artery dissection: analysis of 9 patients and review of the literature. , 2002, Archives of neurology.

[35]  P. Cabre,et al.  Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome. , 2003, Tissue antigens.

[36]  J. Long,et al.  An E-M algorithm and testing strategy for multiple-locus haplotypes. , 1995, American journal of human genetics.

[37]  D. Clayton,et al.  Transmission/disequilibrium tests for extended marker haplotypes. , 1999, American journal of human genetics.

[38]  J. Todd,et al.  A Protective Role of the Environment in the Development of Type 1 Diabetes? , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[39]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[40]  M. A. Kelly,et al.  An investigation of HLA-encoded genetic susceptibility to multiple sclerosis in subjects of Asian Indian and Afro-Caribbean ethnic origin. , 1995, Tissue antigens.

[41]  R. Papais-Alvarenga,et al.  DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro-Brazilians. , 1999, Tissue antigens.

[42]  J. Anaya,et al.  Multiple sclerosis in the tropics: genetic association to STR’s loci spanning the HLA and TNF , 2002, Multiple sclerosis.

[43]  D. Clayton,et al.  Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. , 1996, Brain : a journal of neurology.

[44]  A. Sadovnick,et al.  Factors influencing sib risks for Multiple Sclerosis , 2000, Clinical genetics.

[45]  J. Haines,et al.  Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. , 1998, Human molecular genetics.

[46]  G. Stewart,et al.  The DRB1 Val86/Val86 genotype associates with multiple sclerosis in Australian patients. , 1999, Human immunology.

[47]  H. Erlich,et al.  Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. , 1994, Human immunology.

[48]  Z. Meiner,et al.  HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews. , 1999, Archives of neurology.

[49]  F. Koning,et al.  HLA-DR beta chain residue 86 controls DR alpha beta dimer stability. , 1993, European journal of immunology.